Clinical Trials Logo

Clinical Trial Summary

To investigate long-term treatment outcomes of patients receiving botulinum toxin A therapy for infantile and acquired esotropia.


Clinical Trial Description

Participants: 164 patients with infantile esotropia and 89 patients with acquired esotropia.

Methods: Patients were injected with botulinum toxin into two medial rectus muscles and followed from 1992 to 2005. Patients were evaluated at 1 week, 2, 6 and 12 months, and then yearly post-injection.

Main Outcome Measures: Degree of motor alignment, recurrence rate, incidence of stereopsis, and dissociated vertical deviation along with complications. ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT00746304
Study type Observational
Source National Taiwan University Hospital
Contact
Status Completed
Phase N/A
Start date September 2007
Completion date December 2007

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05527015 - Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near Phase 3
Completed NCT01460355 - Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone Phase 4
Recruiting NCT06077682 - Cycloplegic Refraction in Pediatric Patients With Esotropia Phase 4
Completed NCT02570555 - Strabismus Surgery and Driving Ability
Active, not recruiting NCT00993174 - Surgery for Esotropia Under Topical Anesthesia N/A
Completed NCT01166503 - Early Versus Delayed Surgery for Infantile Esotropia
Completed NCT00000121 - The Prism Adaptation Study (PAS) Phase 3
Active, not recruiting NCT02404324 - Conservative Treatment of Esotropia in Children up to 3 Years Old N/A
Completed NCT04429659 - Changes in Refractive Error in Patients With Both Partially Refractive Esotropia and Amblyopia
Recruiting NCT05615519 - Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus
Completed NCT00000163 - Congenital Esotropia Observational Study (CEOS) N/A
Recruiting NCT01616108 - Bupivacaine Injection of Eye Muscles to Treat Strabismus Phase 2/Phase 3